Life sciences company Thermo Fisher (NYSE:TMO) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 6.2% year on year to $11.01 billion. Its non-GAAP profit of $5.44 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results